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Summary.-Discontinuous density-gradient centrifugation was used to separate
chronic granulocytic leukaemia (CGL) cells in the chronic phase and blast crisis (BC)
into fractions containing granulocytes in individual stages of maturation. The
occurrence of the Fc IgG (FcR) and complement-component receptors (CR1 and
CR2) in each fraction was estimated. It was established that, with increasing yields
of mature granulocytes, the proportion of cells bearing Fc and C3 receptors increased.
The most important finding was that the high- and low-receptor categories of CGL
cells in chronic phase depended on the percentage of FcR+ cells. In the high-receptor
CGL group, in addition to FcR, the proportion of CR1+ and CR2+ cells was also
greater than in the low-receptor CGL group. Some differences in clinical course of
both immunological CGL groups were observed.
LITERATURE about cell-membrane im-
munological markers during granulocyte
differentiation, especially in different
pathological states, is scarce. Since the
acquisition of surface receptors is associ-
ated with immunological and functional
differentiation, the identification of these
structures may be helpful in studies of
granulocyte physiology and classifica-
tion of certain disease states (Ross et al.,
1978). In a previous study we have
observed that AML blasts are poor in
receptors (Harlozinska et al., 1980). The
number of cell-surface markers increases
with differentiation (Rabellino et al., 1978;
Ross et al., 1978; Berridge, 1979; Harlo-
zinska et al., 1980).
In the present study we have observed
this process in CGL cells separated by
discontinuous density-gradient centrifuga-
tion into fractions containing granulocytes
in individual maturation stages, and have
estimated the incidence of the Fc IgG
(FcR) and complement-component C4b
to C3b (CR1) and C3d (CR2) receptors.
Emphasis was placed on determining the
interrelationship of FcR expression, leu-
kaemic granulocyte maturation and the
clinical course of CGL.
MATERIALS AND METHODS
Human subject8.-All hirmunological tests
were performed on peripheral blood cells
of 20 patients with CGL. Fourteen of these
subjects were in the chronic phase of the
disease, whilst 6 were in myeloblastic crises
and made up a separate group. The diagnosis
was established by standard morphological
and cytochemical criteria. The cytochemical
routine determinations included PAS
reaction, lipid staining, acid and alkaline
phosphatases activity, ox-naphthyl acetate
esterase and peroxidase.
In 11 patients with CGL in the chronic
phase, immunological tests were performed
directly after the diagnosis was established
and before initiating treatment, whilst in
3 patients the tests were performed 2, 11
and 13 years after disease onset respectively.
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The latter were under periodic clinical
control and occasionally received small
doses of busulphan. Of 6 patients with
CGL-BC, 4 had the surface markers deter-
mined before treatment had begun, and in
2 this was performed 18 and 10 months
after CGL diagnosis, when symptoms of
blast transformation were observed. In the
first of these patients polycytostatic treat-
ment was started 1 week before the immuno-
logical tests were initiated, whilst the second
patient received only small doses ofbusulphan
at the moment of marker estimation.
The control studies were performed on
blood cells from normal healthy volunteers
20-45 years old.
Separation of cells.-The leukaemic and
normal blood cells were isolated from fresh,
heparinized blood, mixed with an equal
volume of 300 dextran T 500 (Pharmacia,
Sweden) and left standing for 30 min at
room temperature for sedimentation of
erythrocytes. The leucocyte suspension were
then separated into fractions by discontinuous
density-gradient centrifugation according to
Ross et al. (1978), slightly modified (Harlozin'-
ska et al., 1980). Ficoll-Uropoline gradients,
containing 7 density steps over the range
1-05-1-12, were used to separate myeloid
cells according to the maturation stage
associated with different densities. After
centrifugation at 1200 g for 45 min, the cell
layers concentrated at each Ficoll-Uropo-
line density interface were aspirated, washed
with PBS, and counted. Viability of cells
was determined after staining the prepara-
tions with 0.100 trypan blue. The cells
of each density layer were stained with
Wright-Giemsa to determine differential
morphology.
Rosette-forming cells. Cells witlh Fc recep-
tors for IgG were detected by their capacity
to form rosettes with sheep erythrocytes
coated with 75 IgG anti-SRBC antibody
(EA rosettes) according to Stingl & Knapp
(1977) as earlier described in detail (Harlo-
zinska et al., 1980). Cells with C3 receptors
were detected by their capacity to form
rosettes with SRBC coated with 19S anti-
SRBC antibody and complement (EAC
rosettes) (Gupta et al., 1976). Fresh serum of
young BALB/c mice w%as used as a source of
C3d (EACmo-CR2) and fresh rabbit serum as
a source of C3b (EACra-CRI) (Whiteside
et al., 1977). The methods of detecting both
types of EAC rosettes were described in a
previous study (Harlozinska et al., 1980). In
some cases differential counts of rosetted
cells in fractions of individual density layers
were made from Wright-Giemsa-stained
smears. For staining, rosette mixtures were
centrifuged at 100 g for 3 min, resuspended
in 20 ,ul offoetal calf serum, smeared on glass
slides, dried and then stained with Wright-
Giemsa (Ross et al., 1978).
RESULTS
Ficoll-Uropoline gradient permitted the
separation of the myeloid cell series
according to the degree of morphological
maturation, so that young forms of
granulocytes were concentrated in low-
density fractions, whereas polymorpho-
nuclear neutrophils were restricted to
high-density fractions (Tables I, II). This
method yielded sufficient immature cells
for surface-marker analysis. Low-density
fractions contained 20-30% myeloblasts;
fractions at density 1 06-1 07 focused
most of the myelocytes and metamyelo-
cytes, and fractions at density 1-08-1*105
concentrated band forms and polymorphs.
The vast majority of lymphocytes and
nucleated erythroid cells were isolated in
the low-density layers (1-05-1-06) and
were easily distinguished from large young
forms of granulocytes by phase-contrast
microscopy. Each fraction was defined
morphologically by Wright-Giemsa
staining. The expression of FeR and
receptors for complement components
(CR1 and CR2) were estimated in CGL
andCGL-BC cells ofindividual maturation
stages. On the basis ofthese studies it was
possible to distinguish CGL patients
(Table III) according to the number of
cells expressing receptor for the Fe IgG
fragment. A separate group of patients
had the myeloblastic type of CGL-BC
(Table III).
From the data in Table III it can be
seen that the change in Fe IgG receptor
values in cells of CGL patients does not
depend on morphological differences of
the leukaemic cell population, since the
population after dextran isolation and
the morphological composition of the
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TABLE I.-Detection of surface markers in high-receptor COL cells separated by density-
gradient centrifugation from the peripheral blood ofPatient O.N.
Wright-Giemsa morphology (%)*
A--
Pro
0
13
1
5
0
0
0
Myel
13
16
31
30
2
0
0
Mta
11
12
36
30
12
7
2
Band
24
8
19
20
45
31
25
PMN
44
9
9
12
41
60
72
LymX
4
7
3
2
0
1
0
Rosette-forming cells
(%)
EA EACmo EACra
66*5 24*5 57.5
43 5 ND ND
49 0 ND ND
54 0 9*0 ND
65*0 23 0 53 5
69 5 44 0 75BO
85 0 29 0 86 5
* Blast =myeloblast; Pro =promyelocyte; Myel =myelocyte; Mta =metamyelocyte; Band =band form;
PMN =polymorphonuclear neutrophil; Lym =lymphocyte; ND =not done (too few cells).
TABLE II.-Detection of surface markers in low-receptor CGL cells separated by density-
gradient centrifugation from the peripheral blood ofPatient M.A.
Density
layer
(g/ml)
Dextran
1*05
1*06
1 07
1*08
.09
1*105
Number
of
cells
( x 106)
1370-0
24-0
9 .2
15*4
69-6
66-0
26 4
Wright-Giemsa morphology (%)
Blasts Pro Myel Mta Band PMN Lym
2 1 27 13 28 24 5
35 5 51 2 3 2 2
20 6 30 10 10 18 6
0 0 59 20 10 8 2
0 1 2 5 28 63 63
0 0 2 4 24 70 0
0 0 1 5 26 68 0
individual fractions of discontinuous den-
sity gradient were basically similar in all
3 groups of patients. Fig. 1 shows the
comparative values for FcR in individual
patients in the high- and low-receptor
CGL groups in the chronic phase of the
disease, in the CGL-BC group and in
normal leucocytes. The data represent
results after dextran T 500 cell isolation.
As can be seen, even without cell frac-
tionation, certain differences are evident
in the proportion of FcR+ cells. The
lowest marker content was found in the
low-receptor CGL group, intermediate
content in cells of CGL-BC group, and
higher still in the high-receptor group of
CGL cases. The highest FcR content is
found in leucocytes from normal donors.
A similar distribution is obtained on
estimating the C3 components. Fig. 2
illustrates the comparison of means + s.d.
for all studied markers in both groups of
patients in the chronic phase of CGL, in
those with CGL-BC and in normal donors.
Rosette-forming cells
(%)
EA EACmo EACra
7 0 3 0 8-5
1-0 0.0 0.0
3-0 2 0 0.0
3 0 2-0 2-0
13-5 3-5 7-0
16-0 4 0 12-0
16-0 4 0 17-0
The lowest spread of values was in the
low-receptor CGL, the highest in the
high-receptor group and CGL-BC. As can
be seen from Tables I, III and Fig. 2,
CGL cases with a high proportion of
FcR-bearing cells usually contain a high
number of cells expressing both comple-
ment components, and the number of
cells expressing all 3 markers distinctly
increased in high-density fractions with
more mature neutrophils. In this group of
leukaemias the distribution of surface
markers in individual density fractions
was similar to that ofnormal leucocytes.
Table I shows a representative CGL
case whose cells have a high proportion
of surface markers. The earliest marker
was FcR, whose presence could be demon-
strated in low-density fractions containing
mainly immature granulocytes (Fraction
1.05). Cytocentrifuge preparations after
Wright-Giemsa staining of CGL cells
indicated that on the average 14% of the
myeloblasts expressed FcR. This con-
Density
layer
(g/ml)
Dextran
1*05
1 06
1-07
1-08
1.09
1 105
Number
of
cells
( x 106)
270 0
0*4
0 75
1.16
14-0
28 0
15B6
Blast
4
35
1
1
0
1
1
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TABLE III.-Comparative results of surface markers in leukaemic and normal cells
separated by density-gradient centrifugation
Material
1. High-receptor
CGL cells
(FcR > 25%)
2. Low-receptor
CGL cells
(FcR < 20%)
3. CGL inblast crisis
4. Normal leucocytes
umber Density
of layer
,ases (g/ml)
8 Dextran
1-05
1-06-1-07
1-08-1-09
1.105
6 Dextran
1 -05
1-06-1-07
1.08-1-09
1-105
6 Dextran
1 -05
1-06-1 -07
1 08-1-09
1-105
10 Dextran
1 -05
1-06-1-07
1-08
1.09
1-105
Wright-Giemsa morphology (mean%)
Blasts
Pro
5-2
30-1
5-2
0-6
0 4
10-0
16-3
5.9
0 9
4 0
24-0
40 3
26-5
4-2
0-0
0
1-5
0-5
0
0
0
Myel
Mta
31 -0
53 9
70-9
14-8
8-2
22-0
51-0
68-9
24-4
10-4
17 -0
52 -0
56 0
31-5
3 0
2-0
0-5
1-0
0 3
1*0
0-5
Band
PMN
61-9
11-1
22 -4
84-0
91-0
63-5
31 -0
24-1
73 -2
85-6
52-0
7-4
17 -0
63 -5
97-0
70-0
3-0
20-0
50-6
86-8
95-0
Lym
1-9
4 9
1-5
0-6
0-4
4-5
1-7
1*1
1-5
0-2
7-0
0-3
0-5
0-8
0
27-0
95-0
78-5
49-1
11-2
3 -5
Mono
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1-0
0
0
0
1-0
1-0
Surface markers
(mean%)
- - 5
FcR CR2 CR1
44-7 24-9 31-4
19-6 5-5 4-
31-0 14-4 15-2
40.1 21-3 27-4
59-6 24-4 52-3
7-5 5-0 5-4
2-2 1-7 0-5
4-8 2-9 1-2
10-8 5-0 5-4
15-9 7 9 12-3
12-8 7-8 14-8
8-6 3-7 4-0
9 3 4.7 5-8
15-4 9-5 18-5
19-0 10-0 18-0
64-6 20-9 59 7
ND ND ND
ND ND ND
45-3 21-8 34-5
64-9 37-9 57-4
72-6 19-1 67-6
firmed the very early appearance of that
marker in the maturation process of the
myeloid cell line. The number of cells
expressing that marker distinctly in-
creased as the mature granulocyte frac-
tions were obtained. Receptors for both
complement components were present
on a low percentage of young forms of its
myeloid cell series (Table III) and the
number of CR1+ cells increased more
distinctly than CR2+ as more neutrophils
matured.
The second group of leukaemias, desig-
nated as low-receptor CGL, was character-
ized by a low proportion of FcR ( < 20%
in the leucocyte fraction after dextran
isolation). The cell number expressing
this receptor steadily increased as more
mature cells in denser layers were ob-
tained, but the percentage was always
much lower than in the high-receptor
leukaemias (Table III). Similarly, only
a small proportion of cells expressed C3
receptors. The distribution of the sur-
face markers in this CGL group was
similar to the marker values in patients
in blast crisis.
14
Our observations indicate that high-
receptor CGL may have a slightly better
clinical prognosis. Up to the present, only
2 patients from the high-receptor group
have died. In the first patient symptoms of
an unresponsive blast crisis appeared 19
months after diagnosis, whilst the second
patient died without signs of exacerba-
tion after 13-5 years. The rest of the
patients in this group have lived for
11, 3, 2-5 and 2 years and 3 and 2 months
respectively. Only in one ofthese patients
(on polycytostatic therapy) was there a
blast crisis after 2 years of disease. At the
time ofwriting the 6 surviving patients are
in agood clinical and haematological state.
In the low-marker group 2 patients
died 13 and 18 months after diagnosis,
due to a treatment-resistant blast crisis.
A third patient showed signs of exacerba-
tion 11 months after diagnosis of CGL,
and is in a grave general state. One
female patient from this group is alive
after 2-5 years and her condition is
satisfactory. In 2 remaining patients
the marker analysis was performed 2
months after the diagnosis.
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FiG. 1. Distribution of FcR in leucocytes of individual patients with low- and high-receptor CGL in
chronic phase, CGL-BC, and normal leucocytes (dextran isolation).
In the CGL-BC group, 4 patients have
died so far at 4, 6, 23 and 26 months
from diagnosis. In the 2 remaining the
blast crisis was diagnosed and immuno-
logical determinations were performed
only in the last 3 months.
DISCUSSION
According to our immunological findings
we have been able to distinguish 2
subgroups of CGL: one with high-receptor
cells and the other with low-receptor cells.
The most characteristic marker for such
division was the Fc receptor for IgG.
In high-receptor leukaemias, an average
of 20% of immature cells, isolated in
low-density layers, expressed this receptor,
and that percentage increased gradually
to about 60% in the high-density layers
containing morphologically mature poly-
morphs.
In low-receptor leukaemias, the FcR
was detectable on 2% of immature
granulocytes obtained in low-density
layers, and at higher densities the per-
centage of FcR+ cells increased on the
average to only 16% (Table III).
The possible phenotypic heterogeneity
of CGL is already seen in the FcR deter-
minations in cells isolated on dextran
T 500, which is independent of granulo-
cyte separation according to morpho-
logical maturity.
Similar, but less distinct, differences
were found on estimating the proportion
of cells expressing receptors for comple-
ment components. In high-receptor CGL
leukaemias the proportion of cells with
CR1 and CR2 receptors was always much
higher than in low-receptor CGL.
On the basis of observations up to the
present time, it seems that high-receptor
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Fie. 2.-Fe (U) and C3 (CR2, A; CR1, 0) receptors in low- and high-receptor CGL cells in chronic
phase, CGL-BC cells and normal leucocytes. Vertical bars indicate s.d. around means.
CGL patients, containing in their peri-
pheral blood immunologically mature neu-
trophils, with a proportion of surface
markers similar to normal granulocytes,
had a better clinical prognosis, and that
blast crisis or concomitant infections were
rare. This allows us to assume that the
dominance of immunologically immature
malignant clones or subelones inthe picture
of peripheral blood is connected with a
more acute and heavy course of CGL.
Recently Palu et al. (1979a,b) have
shown that the ability of Fc- AML
blasts to induce neoplasms in mice with
a weakened immunological system dis-
tinctly decreases with the acquisition of
Fc and C3 receptors on the surface of
cells cultured in vitro.
A fundamental question raised by our
studies is the origin of high- and low-
receptor CGL cells. Several possibilities
may be considered, including the existence
of subpopulations with different fre-
quencies of EA and EAC rosettes or
blocks that may occur on different
maturation stages of myeloid cells. Some
data indicate that human neutrophils
comprise heterogeneous populations
(Klempner & Gallin, 1978) and Sachs
(1977) has developed an experimental
system for cloning myeloid leukaemia
cells with different capacities for EA-
and/or EAC-rosette formation.
The density-gradient technique ap-
peared to be valuable for concentrating
immature granulocytes (Ross et al., 1978).
Estimation of Fc receptor in these frac-
tions confirmed its presence at an early
phase of neutrophil differentiation (Her-
born et al., 1979; Harlozinska et al., 1980).
aI)
t-
ui)
199
T I200 A. HARLOZIDSKA ET AL.
Fc+ cells increased steadily, reaching the
highest proportion in fractions with
mature polymorphs.
In a previous paper (Harlozin'ska et al.,
1980) we showed that the appearance of
CR1 was preceded by a CR2-type receptor.
Now we have demonstrated that both
types of complement receptors, in all
tested groups, increased up to the frac-
tion of density 1 09, and in fraction
1 105 contained the denser polymorphs,
whilst the number of CR2+ cells does not
change significantly, but the amount of
CR1+ cells continued to rise. In normal
leucocytes and in some cases of "high-
receptor" myeloid leukaemias, the amount
of CR2+ cells in the 1P105 fraction was
significantly reduced. These observations
are consistent with the data of Ross et al.
(1978) indicating that less dense neutro-
phils, containing both CR1 and CR2
receptors, differed in the mechanism of
EAC-rosette formation from their denser
counterparts.
Our studies-especially the demonstra-
tion of high- and low-receptor CGL
forms, despite the similar morphological
patterns in individual density layers-
indicate that regulation of membrane
immunological differentiation may be in-
dependent from maturation as defined by
standard morphological criteria.
This work was supported by the Polish National
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